Annual Review 2020-21Cancer52 is delighted to present its Annual Review 2020-21. This report particularly highlights the strength and impact of Cancer52’s...
Cancer52 is recruiting!Cancer52 requires a Communications Executive to deliver on internal and external communications. The right person will have previous...
Cancer52 is recruiting!Cancer52 requires a professional Executive Assistant to manage an administrative workload. The right person will have previous experience...
22 January 2020 All Member MeetingThe first quarterly All Member Meeting of 2020 is taking place on Wednesday 22nd January 2020, from 10am to 1pm in the Allen Room at St...
13 November 2019 Cancer52/NHS England & Improvement Workshop Rapid Diagnostic Centres & PersRapid Diagnostic Centres (RDCs) and the roll out of personalised care are cornerstones of the implementation plans for Cancer Alliances...
16 October 2019 All Stakeholder BriefingThe annual All Stakeholder Briefing was a great success and we had a good turnout of both member organisations and pharmaceutical...
‘Getting a better deal for people with rare and less common cancers: what we can learn from patientsOn Wednesday 10th July we launched a new report, ‘Getting a better deal for people with rare and less common cancers: what we can learn...
4th April 2019 - Cancer52 RoundtableCancer52 held a roundtable on 4th April 2019 to explore the implications of the NHS Long Term Plan and what it means for rare and less...
10th April 2019 All Members MeetingThe All Member Meeting featured a great mix of speakers - Jess Mills of Act for Cancer; and Mary-Jo Pryor of NHSE Specialised...
Briefing on the 2019 Voluntary Scheme for Branded Medicines from the Association of the British PharSlides from the recent Briefing on the 2019 Voluntary Scheme for Branded Medicines from the Association of the British Pharmaceutical...